Clinically related to NF1 mutations, heterozygous variants in the SPRED1 gene, encoding another negative regulator of RAS–MAPK signaling, were reported in Legius syndrome, an autosomal dominant disorder that shows some similarities to NF1 but is less severe [19,20]. This evidence concerns the gene NF1 and Legius syndrome.